Arginine Metabolites as Biomarkers of Myocardial Ischaemia, Assessed with Cardiac Magnetic Resonance Imaging in Chronic Kidney Disease

Ranjit J. Shah,Sara Tommasi,Randall Faull,Jonathan M. Gleadle,Arduino A. Mangoni,Joseph B. Selvanayagam
DOI: https://doi.org/10.3390/biom11030416
IF: 6.064
2021-03-11
Biomolecules
Abstract:(1) Background: Cardiovascular disease (CVD) is the major cause of morbidity and mortality in patients with chronic kidney disease (CKD). Myocardial oxygenation and perfusion response to stress, using oxygen-sensitive cardiovascular magnetic resonance (OS-CMR) and stress T1 mapping respectively, are impaired in CKD patients with and without known coronary artery disease (CAD). Endothelial dysfunction, assessed by circulating levels of asymmetric dimethylarginine (ADMA) and homoarginine (HMA), promotes atherosclerosis. We hypothesized that in CKD patients, worsening endothelial dysfunction is associated with worsening myocardial oxygenation and perfusion as assessed by change in OS-CMR signal intensity (Δ OS-CMR SI) and stress T1 (ΔT1) values. (2) Methods: 38 patients with advanced CKD underwent cardiovascular magnetic resonance (CMR) scanning at 3 Tesla. OS-CMR and T1 mapping images were acquired both at rest and after adenosine stress and analyzed semi-quantitatively. Serum ADMA and HMA concentrations were assessed using mass spectrometry. (3) Results: There was no significant correlation between Δ OS-CMR SI and ADMA or HMA. Interestingly, there was a significant negative correlation seen between Δ T1 and ADMA (r = −0.419, p = 0.037, n = 30) but not between Δ T1 and HMA. (4) Conclusions: Stress T1 response is impaired in CKD patients and is independently associated with higher circulating ADMA concentrations.
biochemistry & molecular biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is whether arginine metabolites can be used as biomarkers for myocardial ischemia in patients with chronic kidney disease (CKD). Specifically, the researchers hypothesized that in CKD patients, as endothelial dysfunction worsens (assessed by the levels of asymmetric dimethylarginine (ADMA) and homoarginine (HMA) in the circulation), myocardial oxygenation and perfusion (assessed by oxygen - sensitive cardiovascular magnetic resonance imaging (OS - CMR) and stress T1 mapping respectively) will also worsen. The research background indicates that cardiovascular disease (CVD) is the main cause of morbidity and mortality in CKD patients. Although traditional CVD risk factors such as hypertension and hypercholesterolemia are common in patients with advanced CKD, they can only partially explain the increased susceptibility to CVD in this group. Almost all known CVD risk factors are associated with endothelial dysfunction, which plays a key role in the pathogenesis of CVD, accompanied by inflammation and atherosclerosis. Endothelial dysfunction is usually manifested as a reduction in nitric oxide (NO) synthesis, which not only promotes the development of atherosclerotic CVD but also leads to the deterioration of renal function. Therefore, this study aims to explore the associations between several arginine metabolites and markers of myocardial ischemia in CKD patients. In particular, it is hypothesized that higher ADMA concentrations and lower HMA concentrations are associated with the deterioration of myocardial oxygenation and perfusion. Through this exploration, the study hopes to find biomarkers that can more accurately predict or assess the cardiac health status of CKD patients.